Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataluren in nonsense-mutation-mediated cystic fibrosis
NCT01140451Phase 3Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Aug 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of ataluren in cystic fibrosis (CF), sponsored by PTC Therapeutics, Inc.. Started Aug 2010; status: completed.
02
Drugs
ataluren
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01140451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140451.